Report on preclinical data for a small-molecule diabetes candidate tested in an animal model and its potential development implications.
Key Takeaways
- Telomir-Zn restored insulin sensitivity in a diet-induced zebrafish model dose-dependently
- HOMA-IR declined from about 10–12 to roughly 3 after 14 days of treatment
- Compound has FDA IND clearance for a Phase 1/2 triple-negative breast cancer trial